MEGUIAR'S G37 - Manual (Page 24)

G123, PlastX (22-121A): G12306, G12310
__________________________________________________________________________________________
Page: 7 of 15
10.3 Possibility of hazardous reactions
Hazardous polymerisation will not occur.
10.4 Conditions to avoid
Heat.
10.5 Incompatible materials
Strong acids.
Strong oxidising agents.
10.6 Hazardous decomposition products
Substance Condition
None known.
Refer to section 5.2 for hazardous decomposition products during combustion.
SECTION 11: Toxicological information
The information below may not be consistent with the material classification in Section 2 if specific ingredient
classifications are mandated by a competent authority. In addition, toxicological data on ingredients may not be
reflected in the material classification and/or the signs and symptoms of exposure, because an ingredient may be
present below the threshold for labelling, an ingredient may not be available for exposure, or the data may not be
relevant to the material as a whole.
11.1 Information on Toxicological effects
Signs and Symptoms of Exposure
Based on test data and/or information on the components, this material may produce the following health effects:
Inhalation
Respiratory tract irritation: Signs/symptoms may include cough, sneezing, nasal discharge, headache, hoarseness, and nose
and throat pain.
Skin contact
Skin Irritation: Signs/symptoms may include localized redness, swelling, itching, dryness, cracking, blistering, and pain.
Eye contact
Contact with the eyes during product use is not expected to result in significant irritation.
Ingestion
Gastrointestinal irritation: Signs/symptoms may include abdominal pain, stomach upset, nausea, vomiting and diarrhoea.
Toxicological Data
If a component is disclosed in section 3 but does not appear in a table below, either no data are available for that endpoint or
the data are not sufficient for classification.
Acute Toxicity
Name Route Species Value
Overall product Ingestion No data available; calculated ATE >5,000 mg/kg
Solvent naphtha (petroleum), medium aliphatic Inhalation-
Vapor LC50 estimated to be 20 - 50 mg/l
Solvent naphtha (petroleum), medium aliphatic Dermal Rabbit LD50 > 3,000 mg/kg
Solvent naphtha (petroleum), medium aliphatic Ingestion Rat LD50 > 5,000 mg/kg